Vivoryon Therapeutics N.V. buy melinda
Start price
26.11.17
/
50%
€11.80
Target price
16.01.18
€17.00
Performance (%)
23.74%
End price
16.01.18
€14.60
Summary
This prediction ended on 16.01.18 with a price of €14.60. The BUY prediction by melinda finished with a performance of 23.74%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Vivoryon Therapeutics N.V. | -13.625% | -13.625% | -94.833% | -95.150% |
iShares Core DAX® | 0.000% | -2.064% | 13.111% | 16.685% |
iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% | 43.441% |
iShares Nikkei 225® | 1.568% | -5.892% | 19.592% | 4.617% |
iShares S&P 500 | 0.334% | -2.281% | 27.745% | 41.046% |
According to melinda what are the pros and cons of Vivoryon Therapeutics N.V. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Vivoryon Therapeutics AG diskutieren
Probiodrug ist auf die Erforschung und Entwicklung von therapeutischen Produkten für die Behandlung der Alzheimer-Krankheit. Am Ende 2016 hat die Gruppe einen Portfolio von Produkten 2 in der vorklinischen Entwicklung (PBD-C06 und PQ1565) und ein Produkt in der Phase IIa
(Vom Mitglied beendet)
Stopped prediction by melinda for Vivoryon Therapeutics N.V.
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€18.36
27.11.21
27.11.21
€19.00
27.11.22
27.11.22
-50.44%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€3.80
16.03.20
16.03.20
€5.00
04.11.21
04.11.21
437.55%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€5.48
26.02.20
26.02.20
€7.50
16.03.20
16.03.20
-30.75%
16.03.20
16.03.20
Could be worthwhile Investment >10% per year
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€11.80
26.11.17
26.11.17
€17.00
16.01.18
16.01.18
23.74%
16.01.18
16.01.18
Could be worthwhile Investment >10% per year